Biography
Dr. Kevin Song is the director of the Hematology Research Program and a clinical professor in the Division of Hematology at the University of British Columbia. He is also the interim medical director of the Leukemia/BMT Program of British Columbia. He trained in hematology and then as a leukemia/bone marrow transplant fellow in Vancouver from 1998–2001. He did further bone marrow transplant training in Toronto before joining the Leukemia/Bone Marrow Transplant Program attending staff in 2002. Dr. Song’s research interests include the treatment of myeloma and other plasma cell dyscrasias and the use of hematopoietic stem cell transplant to treat non-Hodgkin’s lymphoma.
Research Studies
Blood, Heart and Circulation, Cancers
Comparing treatments for newly diagnosed multiple myeloma patients
Blood, Heart and Circulation, Multiple Myeloma
An Investigational Immuno-therapy Study of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma (CheckMate 602)
Blood, Multiple Myeloma
A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Subjects With Newly Diagnosed Multiple Myeloma
Immune System and Disorders, Lymphoma, Cancers
A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) (ZUMA-1)
Blood, Multiple Myeloma
A Study in Subjects With Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination With Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing (ARROW)
Publications
- Cancer medicine -
- Blood advances -
- Leukemia & lymphoma -
- Leukemia -
- Clinical lymphoma, myeloma & leukemia -
